Not recommended for pregnant or breastfeeding women, adolescents or people on medication
The Lancet , 398 (10295), 143-155
Prescribers and registered dietitians may monitor weight trend, waist change, strength, dietary intake, labs, and symptoms
We specialize in sexual enhancement, weight loss, hormone replacement and general wellness
Glycemic Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonist on Top of Sodium-Glucose Co-Transporter-2 Inhibitor Treatment Compared to Sodium-Glucose Co-Transporter-2 Inhibitor Alone: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Childs BG, Gluscevic M, Baker DJ, Laberge RM, Marquess D, Dananberg J, van Deursen JM